Management of Chronic Neuritis with an Extended and Continuous Course of Prednisolone and Methotrexate: A Case Report
American Journal of Clinical and Experimental Medicine
Volume 2, Issue 6, November 2014, Pages: 171-174
Received: Dec. 8, 2014; Accepted: Dec. 17, 2014; Published: Dec. 22, 2014
Views 2321      Downloads 94
Author
Delwar Hossain, Department of Dermatology and Venereology, University of Science and Technology Chittagong (USTC), Chittagong, Bangladesh
Article Tools
Follow on us
Abstract
Patients may have prolonged neuritic episode in the field of leprosy. In that case, one or few interrupted courses of prednisolone of 4-months duration may prove inadequate for the unduly suffering patients. With an intention to see whether a prolonged course of prednisolone and methotrexate could be of any help for them, a patient having neuritis in several nerves including multiple abscesses in the right sural nerve was treated with a 15 months extended and continuous course of prednisolone and methotrexate. The outcome was complete and permanent remission with full functional recovery. Few mild self-limiting side effects from prednisolone were seen. However, there was no side effect from methotrexate. In conclusion, extended and continuous course of prednisolone and methotrexate was found safe and effective in treating a case of chronic neuritis.
Keywords
Leprosy, Chronic neuritis, Treatment, Prednisolone, Methotrexate
To cite this article
Delwar Hossain, Management of Chronic Neuritis with an Extended and Continuous Course of Prednisolone and Methotrexate: A Case Report, American Journal of Clinical and Experimental Medicine. Vol. 2, No. 6, 2014, pp. 171-174. doi: 10.11648/j.ajcem.20140206.20
References
[1]
Job CK. Nerve damage in reversal reaction. Ind J Lepr, 1996; 68: 43-47.
[2]
Kar BR, Babu R. Methotrexate in resistant ENL. Int J Lepr Other Mycobact Dis, 2004; 72: 4: 480-82.
[3]
Delwar Hossain. Using methotrexate to treat patients with ENL unresponsive to steroid and clofazimine: A report on 9 patients. Lepr Rev, March, 2013; 84 (1): 105-112.
[4]
Stephen L. Walker and Diana N. J. Lockwood. Leprosy type 1 (reversal) reactions and their management. Lepr Rev, 2008; 79: 372-386.
[5]
Rose P, Waters MFR. Reversal reaction in leprosy and their management. Lepr Rev, 1991; 62: 113-21.
[6]
Einar P Wilder-Smith and Wim H Van Brakel. Nerve damage in leprosy and its management. Nature Clinical Practice, 2008; 4: 656-663.
[7]
David M. Scollard. The biology of nerve injury in leprosy. Lepr Rev, 2008; 79: 242-253.
[8]
Naafs B. Treatment of reactions and nerve damage. Int J Lepr, 1996; 64: S21-28.
[9]
Swierkot J, Szechinski J. Methotrexate in rheumatoid arthritis. Pharmacol Rep, 2006; 58: 473-92.
[10]
Onwukwe MF. Treating keloids by surgery and methotrexate. Arch Dermatol, 1980; 116: 158.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186